Abstract
Near-term disease forecasting and scenario projection efforts rely on the availability of data to train and evaluate model performance. In most cases, more extensive epidemiological time series data can lead to better modeling results and improved public health insights. Here we describe a procedure to augment an epidemiological time series. We used reported flu hospitalization data from FluSurv-NET, the National Healthcare Safety Network, and flu outpatient visits from ILINet to estimate a complete time series of flu hospitalization counts dating back to 2009. The augmentation process includes concatenation, interpolation, extrapolation, and imputation steps, each designed to address specific data gaps. We demonstrate the forecasting performance gain when the extended time series is used to train flu hospitalization models at the state and national level.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by a subaward to Signature Science, LLC from the Council of State and Territorial Epidemiologists (CSTE) via the Centers for Disease Control and Prevention (CDC) Cooperative Agreement No. NU38OT000297.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at: https://healthdata.gov/Hospital/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/g62h-syeh/about_data and https://gis.cdc.gov/GRASP/Fluview/FluHospRates.html
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We adapted our methodology to account for ILINet data as a predictor in the imputation procedure. Additionally, output datasets now span through the 2023-24 flu season.
Data Availability
All data and code produced are available online at: https://zenodo.org/records/16584391
7 Data Availability
The code and required data for the full augmentation process and the imputation results described here can be found at DOI 10.5281/zenodo.13146376.
